TRIM25 and breast cancer: Mechanistically, CTSGDP-13 interfered with the ferroptosis inhibitory activity of TRIM25, which itself is significantly upregulated in BC patients mainly through binding to the coiled-coil domain of TRIM25, and thereby, it impaired the binding of TRIM25 to the deubiquitinase USP7 (Figure 5).